ctrl K

Watchlist Price Alert

Ascentage Pharma Group In... (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

31.51

-0.62 (-1.93%)

At close: Jun 17, 2025, 3:30 PM

Ascentage Pharma International Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2018	Q1 2017
Period Ending	Mar 31, 2018	Mar 31, 2017
Revenue	416.46K	275.25K
Cost of Revenue	781.33K	276.84K
Gross Profit	-364.86K	-1.6K
Operating Income	-9.67M	-2.47M
Interest Income	n/a	n/a
Pretax Income	-5.67M	-3.6M
Net Income	-5.55M	-3.54M
Selling & General & Admin	2.36M	787.26K
Research & Development	6.95M	1.68M
Other Expenses	n/a	n/a
Operating Expenses	9.31M	2.47M
Interest Expense	4.37M	1.98M
Selling & Marketing Expenses	n/a	n/a
Cost & Expenses	-10.09M	-2.75M
Income Tax Expense	-121.27K	-58.21K
Shares Outstanding (Basic)	49.17M	49.17M
Shares Outstanding (Diluted)	49.17M	49.17M
EPS (Basic)	-0.11	-0.07
EPS (Diluted)	-0.11	-0.07
EBITDA	-523.95K	-1.34M
EBIT	-1.31M	-1.62M
Depreciation & Amortization	781.33K	276.84K